Digital Journal

Softgel Capsule Market to Surpass USD 14.06 Billion by 2031 Driven by Rising Demand for Nutraceuticals and Technological Advancements

0


The Softgel Capsule Market is poised for significant growth, reaching a projected valuation of USD 14.06 billion by 2031 from USD 8.18 Billion in 2023. This upsurge will be fueled by a CAGR of 7% throughout the forecast period (2024-2031).

Softgel Capsules Market Driven by Innovation and Health

Softgel capsules offer numerous benefits like easy swallowing, taste masking, and improved drug absorption. Advancements in technology are introducing features like controlled release and tamper-evident properties, making them a versatile choice for pharmaceuticals. Additionally, the rise of plant-based capsules caters to vegetarians and promotes sustainability. The nutraceutical boom, focus on healthy living, and the COVID-19 pandemic have further driven market growth. Research on potent drugs and patient preference for capsules solidify the promising future of this market.

Get Free Sample Report of Softgel Capsule Market @ https://www.snsinsider.com/sample-request/1183

List of Softgel Capsule Companies Profiled in Report:

  • Weihai Baihe Biology Technological Co. Ltd.
  • Soft Gel Technologies Inc.
  • Captek softgel International Inc.
  • Patheon (part of Thermo fisher scientific)
  • Catalent Inc.
  • Capsugel (a part of lonza)
  • Strides Pharma Science Limited
  • Amway
  • EuroCaps Ltd.
  • International Vitamin Corporation
  • Sirio Pharma Co. Ltd

Softgel Capsule Innovation Heats Up with Acquisitions and R&D

Fierce competition is driving rapid advancements in softgel capsule technology. Companies are investing heavily in R&D to develop novel formats like “capsule in capsules” and controlled release medications. Outsourcing production is a growing trend, allowing manufacturers to cut costs and stay competitive.

  • In January 2023, Sirio Pharma bought Best Formulations, a manufacturer of gummies and softgels made from plant fibre. The acquisition is expected to significantly improve Sirio Pharma’s production capacity, portfolio of products and R&D capabilities.
  • Similarly, in April 2022, Catalent announced that it had acquired from the Vaccine Manufacturing and Innovation Centre UK Limited VMIC Ltd. a development and manufacturing facility for Biologics.

These developments solidify the commitment to innovation and position the softgel capsule market for continued growth.

Softgel Capsule Industry Segmentation as Follows:

By Type

  • Gelatin/ Animal-Based
  • Non-animal Based

By Application

  • Antacid & Anti-flatulent Preparations
  • Vitamin & Dietary Supplement
  • Antibiotic & Antibacterial Drugs
  • Cough & Cold Preparations
  • Anti-anemic Preparations
  • Health Supplement
  • Anti-inflammatory Drugs
  • Pregnancy

By Manufacturers

  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Nutraceutical Companies
  • Cosmeceutical Companies

Gelatin Holds Supreme Position

Gelatin-based capsules continue to dominate the softgel market, holding the largest revenue share in 2023. This dominance is attributed to gelatin’s unmatched advantages. For over eight decades, manufacturers have favored gelatin due to its ease of digestion, tamper-evident properties, superior strength, reliable seals, and patient compliance. Additionally, gelatin’s natural abundance, inert nature, and clean-label appeal further solidify its market position. The trend of combining bovine and porcine gelatin sources is gaining traction. Bovine gelatin contributes to capsule firmness, while porcine gelatin offers desirable plasticity. This strategic blend allows manufacturers to leverage the unique strengths of both sources, ensuring optimal capsule performance. Although this segment faces competition from plant-based alternatives, gelatin’s long-standing reputation and unparalleled functionality maintain its reign as the king of softgel capsules.

Ask Your Query Before Buying this Research Report @ https://www.snsinsider.com/enquiry/1183

Softgel Capsule Market
Softgel Capsule Market

Key Regional Developments

North America dominated the market with a leading revenue share of 45% in 2023, attributed to factors such as advanced production technology, the presence of major market players in the region, and high investments in R&D activities aimed at expanding product portfolios. Additionally, the high concentration of health-conscious consumers and leading pharmaceutical companies in North America further contribute to the strong market growth in the region.

Over the forecast period, Asia Pacific is expected to be the fastest growing region, primarily driven by the significant presence of generic medicine manufacturers in China and India, the rising demand for cost-efficient therapeutic solutions, rapidly improving economic conditions, and the increasing number of contract manufacturing organizations within the region. The growing expenditure on personalized medicine and the adoption of advanced technologies to enhance softgel production are also likely to propel market growth in this region.

War and Slowdown Having Negative Impact On Softgel Capsules Market

The Russia-Ukraine war disrupts the softgel capsule market. Supply chain issues and sanctions limit access to raw materials, especially gelatin, causing price hikes and potential shortages. Additionally, diverted healthcare spending due to the war might decrease demand for non-essential supplements. However, the war presents a silver lining. The focus on self-care boosts sales of essential vitamin and dietary supplement softgels. Moreover, companies seek alternative sourcing locations, potentially fostering new suppliers. An economic slowdown can also pose challenges. Reduced healthcare spending may prioritize essential medications over supplements. Lower R&D investments could hinder innovation. Yet, this scenario presents opportunities. As consumers become price-conscious, demand for cost-effective nutraceuticals and generic drugs packaged in softgels might rise. Furthermore, manufacturers might prioritize cost-reduction strategies, leading to more competitive softgel capsule solutions.

By Purchasing This Report, You Gain A Comprehensive Understanding Of:

  • Current market trends and future growth projections
  • Technological advancements influencing the industry
  • Consumer preferences and evolving needs
  • The influence of geopolitical and economic factors on the market
  • Lucrative regional opportunities for market expansion

Buy Softgel Capsule Market report @ https://www.snsinsider.com/checkout/1183

Table of Content

Chapter 1 Introduction

Chapter 2 Research Methodology

Chapter 3 Softgel Capsule Market Dynamics

Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Softgel Capsule Market Segmentation, By Type

Chapter 9 Softgel Capsule Market Segmentation, By Application

Chapter 10 Softgel Capsule Market Segmentation, By Manufacturers

Chapter 11 Regional Analysis

Chapter 12 Company profile

Chapter 13 Competitive Landscape

Chapter 14 Use Case and Best Practices

Chapter 15 Conclusion

Continued…

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/



Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

ED

Next Generation Sequencing Market Surges on Clinical Applications, Projected to Reach USD 40.97 Billion by 2031

Previous article

Wearable Medical Devices Market Experiences 25.7% CAGR, Surpassing USD 210 Billion by 2031, Driven by Rising Chronic Diseases and Focus on Preventive Care

Next article

You may also like

Comments

Comments are closed.